quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:28:34·23d
SECFiling
VYNE Therapeutics Inc. logo

SEC Form S-4 filed by VYNE Therapeutics Inc.

VYNE· VYNE Therapeutics Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • VYNE
    VYNE Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Jul 31UpdateBTIG Research-
  • Nov 18UpdateBTIG Research$8.00
  • Dec 6UpdateHC Wainwright & Co.$7.00

Related

  • INSIDER21d
    SEC Form 4 filed by Zeronda Tyler
  • INSIDER21d
    SEC Form 4 filed by Stuart Iain
  • INSIDER21d
    SEC Form 4 filed by Harsch Mutya
  • INSIDER21d
    SEC Form 4 filed by Domzalski David
  • SEC43d
    SEC Form 8-K filed by VYNE Therapeutics Inc.
  • SEC55d
    SEC Form 10-K filed by VYNE Therapeutics Inc.
  • SEC83d
    SEC Form 425 filed by VYNE Therapeutics Inc.
  • SEC83d
    VYNE Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022